Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis.
Stein DJ, Pedersen R, Rothbaum BO, Baldwin DS, Ahmed S, Musgnung J, Davidson J. Stein DJ, et al. Among authors: ahmed s. Int J Neuropsychopharmacol. 2009 Feb;12(1):23-31. doi: 10.1017/S1461145708008961. Epub 2008 Jun 11. Int J Neuropsychopharmacol. 2009. PMID: 18544181 Free article. Clinical Trial.
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT. Keller MB, et al. Among authors: ahmed s. J Clin Psychiatry. 2007 Aug;68(8):1246-56. doi: 10.4088/jcp.v68n0812. J Clin Psychiatry. 2007. PMID: 17854250 Clinical Trial.
Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study.
Kornstein SG, Kocsis JH, Ahmed S, Thase M, Friedman ES, Dunlop BW, Yan B, Pedersen R, Ninan PT, Li T, Keller M. Kornstein SG, et al. Among authors: ahmed s. Int Clin Psychopharmacol. 2008 Nov;23(6):357-63. doi: 10.1097/YIC.0b013e328314e2cb. Int Clin Psychopharmacol. 2008. PMID: 18854724 Free PMC article. Clinical Trial.
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Dunlop BW, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen R, Yan B, Ahmed S, Schmidt M, Ninan PT. Keller MB, et al. Among authors: ahmed s. Biol Psychiatry. 2007 Dec 15;62(12):1371-9. doi: 10.1016/j.biopsych.2007.04.040. Epub 2007 Sep 7. Biol Psychiatry. 2007. PMID: 17825800 Clinical Trial.
Predominance of Dengue virus type 2-genotype II (Cosmopolitan) in Bangladesh, 2023: Presumptive sudden replacement of a prevailing virus strain.
Begum R, Paul SK, Aung MS, Haque N, Ahmed S, Islam A, Nila SS, Roy S, Jahan A, Sathi FA, Al Mamun A, Biswas JP, Kobayashi N. Begum R, et al. Among authors: ahmed s. New Microbes New Infect. 2024 May 15;60-61:101431. doi: 10.1016/j.nmni.2024.101431. eCollection 2024 Aug-Oct. New Microbes New Infect. 2024. PMID: 38818244 Free PMC article. No abstract available.
12,288 results
You have reached the last available page of results. Please see the User Guide for more information.